Oil Markets Near Tipping Point as USIran Talks Accelerate Potential Impact on Global Economy Milburn Criticizes Shameful Spending Disparity on Youth Benefits vs Jobs ONGC Reports 46 Surge in Q4 Net Profit Revenue Up 4 Tech Media Telecom Roundup Market Talks Focus on AI and Fintech Developments Borosil Glass Works Surges Over 200 in One Year on Strong Revenue and EBIDTA Growth Palantir Technologies Stock Declines 34 from Recent Highs Market Analysis Mesa Laboratories Inc MLAB Q1 2026 Earnings Strong EPS Surprise of 130 Amid Quiet Revenue Disclosure FCNCO Q1 2026 Earnings Preferred Shares Deliver Strong EPS Surprise Amid Steady Underlying Performance Investors Title Company ITIC Q4 2025 Earnings Strong EPS Performance Amid Quiet Period Ovintiv Inc OVV Q1 2026 Earnings EPS Beats Estimates Amid Solid Execution DocuSign Q1 2026 Earnings EPS Beats Estimates Amid Focus on Operational Efficiency Nuvalent Inc NUVL Q1 2026 Earnings Slightly Wider Loss No Revenue Yet as PreClinical Pipeline Progresses Dorchester Minerals LP DMLP Declines 24 as Energy Sector Headwinds Persist Fractyl Health GUTS Dips 3 as Stock Hovers Near Critical Support at 085 PepsiCo PEP Edges Higher as Dividend Strength and Defensive Appeal Support Price Action Nexa Resources NEXA Climbs Higher as Support Holds Steady Air Industries Group AIRI Rallies to 307 Testing Key Resistance Levels BILL Holdings Q1 2026 Earnings EPS Smashes Estimates as Platform Gains Traction NVEC Q1 2026 Earnings EPS of 102 Drives Share Price Rally Magyar Bancorp Inc MGYR Q4 2025 Earnings EPS of 040 Achieved Stock Unchanged VNRX Q1 2026 Earnings EPS Misses Estimates Stock Surges on Strategic Progress AbbVie ABBV Q1 2026 Earnings Slight EPS Beat Amid Solid Operational Execution UTHR Q1 2026 Earnings EPS Misses Estimates as Operational Costs Weigh on Results Flowers Foods Reaffirms FullYear Guidance Amid Input Cost Pressures BBLG Q1 2026 Earnings EPS Surprises to the Upside Despite No Revenue Stock Declines RingCentral RNG Surges 31 as Shares Test Key Resistance Near 4572 Eupraxia Pharmaceuticals EPRX Q1 2026 Earnings Clinical Progress Overshadows Slight EPS Miss Camden National Corporation CAC Q1 2026 Earnings EPS Beats Estimates Amid Slightly Negative Market Reaction NRX Pharmaceuticals Q1 2026 Earnings Wider Loss Despite No Revenue Stock Advances TWST Q1 2026 Earnings EPS Misses Estimates as Shares Rally on Operational Progress QTTB Q1 2026 Earnings Narrowed Loss Drives Significant Stock Surge RNGR Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Details Remain Unclear MOMO Q4 2025 Earnings EPS Misses Estimates by 4529 as Stock Rises 151